Eisai Receives Regulatory Review Outcome for Lecanemab as a Treatment for Early Alzheimer’s Disease in Australia

TOKYO and CAMBRIDGE, Mass., Mar 4, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. and Biogen Inc. announced today that the Therapeutic Goods Administration (TGA) of Australia has confirmed the initial decision to decline the approval of humanized anti-soluble aggregated amyloid-beta (Aβ) monoclonal antibody lecanemab (generic name) as…

NTT and DOCOMO Successfully Demonstrates On-Demand Unified Control of Computing Services Through Network and Service Integration

TOKYO, Mar 3, 2025 - (JCN Newswire via SeaPRwire.com) - NTT Corporation (NTT) and NTT DOCOMO, INC. announced today that they have successfully demonstrated the effectiveness and feasibility of In-Network Computing (INC),*1 an architecture that integrates and coordinates computing resources for services such as AI and mobile networks to enable…

Space Compass and NTT DOCOMO Successfully Demonstrate Data Connectivity to 4G Devices via HAPS at 20 km Above Kenya

TOKYO, Mar 3, 2025 - (JCN Newswire via SeaPRwire.com) - Space Compass and NTT DOCOMO, INC. jointly announced today that they have successfully completed data connectivity tests between the LTE base station and smartphones using high-altitude platform stations (HAPS)(1) from the stratosphere (altitudes of around 20km) in Laikipia County, Kenya.In…

Eisai Enters into License Agreement for the Development and Distribution of Fibroblast Growth Factor (FGF) Receptor Selective Tyrosine Kinase Inhibitor Tasurgratinib in Greater China Region (Mainland China, Hong Kong, Macau, and Taiwan) with SciClone

TOKYO, Feb 28, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. announced today that the company has entered into a license agreement granting the exclusive development and distribution rights for the fibroblast growth factor (FGF) receptor selective tyrosine kinase inhibitor tasurgratinib succinate (generic name, development code: E7090, Japan…

Mazda Production and Sales Results for January 2025

Mazda Motor Corporation's production and sales results for January 2025 are summarized below.I. Production1. Domestic ProductionMazda's domestic production volume in January 2025 increased 22.6% year on year due to increased production of passenger vehicles.[Domestic production of key models in January 2025]CX-5:25,266 units(down 2.0% year on year)MAZDA3:8,479 units(up 33.5%)CX-30:6,571 units(up 6.8%)2.…

MovieCoin (MOV) Shaping the Future of Film Investment with Winvest Group

Reno, Nevada – February 26, 2025 – (SeaPRwire) – A visionary investment team has launched MovieCoin (MOV), a blockchain-powered financing platform designed to support Winvest Group’s (OTCQB: WNLV) development in movie production and Launchrr aggregation platform. MOV leverages a new financial model to bridge crypto investment with traditional capital markets, fostering long-term…

Paglulunsad ng UPCX API: Paano Maaaring Pukawin ng mga Developer ang Susunod na Malaking Hakbang sa Blockchain Payments

Bilang isang matagal nang tagamasid ng industriya sa blockchain at fintech, matagal ko nang inaasahan ang isang proyekto na tunay na makakapag-reshaping ng tanawin ng mga pagbabayad. Sa mga inobasyong lumitaw, ang mga kamakailang hakbang ng UPCX ay talagang kahanga-hanga. Hindi lamang naging opisyal na sponsor ng blockchain payment ang…